It is probable that LSD2, in collaboration with LSD1, provides an additional layer of epigenetic modification in governing breast cancer stem cell features through modulation of the level of H3K4 methylation at pluripotent regulatory genes. The gene discussed is KDM1B; the disease is breast cancer.